Diatranz Otsuka Limited clinical trials

Acquired by Otsuka Holdings Co., Ltd.

The registry lists 2 studies whose lead sponsor is Diatranz Otsuka Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 20, 2017.

Status

Completed: 2

Phase

Phase 1: 2
Phase 2: 2

Where

New Zealand: 1
Argentina: 1

Registry sponsor names on this page

Diatranz Otsuka Limited2 studies

Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Otsuka Holdings Co., Ltd. studies →

Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes MellitusCompletedNCT01739829Phase 1/2
Sponsor listed in the registry: Diatranz Otsuka Limited · Diatranz Otsuka Limited — acquired company within the Otsuka Holdings Co., Ltd. group
Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes MellitusCompletedNCT00940173Phase 1/2
Sponsor listed in the registry: Diatranz Otsuka Limited · Diatranz Otsuka Limited — acquired company within the Otsuka Holdings Co., Ltd. group